Neuphoria Therapeutics Inc.

NEUP · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 8 employees
89
SEC Filings
$3.77
Close 2026-09-04
8
Employees

Business Summary

Neuphoria Therapeutics Inc. is a Delaware-incorporated clinical-stage biotechnology company focused on alpha7 nicotinic acetylcholine receptor modulators. Its lead candidate, BNC210, is an oral negative allosteric modulator evaluated for SAD and PTSD. Following the failed Phase 3 AFFIRM-1 trial in SAD, the company restructured, discontinued internal R&D, and is pursuing a merger with Scancell Holdings plc while maintaining partnered programs with Merck, Pfizer (via CTx CRC), and Carina Biotech.

Latest Stock Quote

NEUP 2026-09-04 $3.77 O:$3.74 H:$3.78 L:$3.73 Vol:0.0M VWAP:$3.7501
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-09-182026-06-300001193125-26-395536EDGAR106K words
2025-09-292025-06-300001193125-25-223338EDGAR103K words
2024-09-302024-06-300001213900-24-082909EDGAR110K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-172025-12-310001193125-26-054509EDGAR25K words
2025-11-142025-09-300001193125-25-281579EDGAR19K words
2025-05-202025-03-310000950170-25-075175EDGAR24K words
2025-02-142024-12-310000950170-25-020473EDGAR25K words
2024-11-142024-09-300000950170-24-127032EDGAR18K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-07-240001213900-26-081052EDGAR8K words
2026-01-080001213900-26-002245EDGAR7K words
2025-12-180001213900-25-123289EDGAR1K words
2025-12-170001213900-25-122777EDGAR1K words
2025-10-270001213900-25-102607EDGAR1K words
2025-10-200001213900-25-100371EDGAR1K words
2025-09-160001213900-25-087950EDGAR1K words
2025-07-180001213900-25-065723EDGAR1K words
2025-05-200001213900-25-045970EDGAR1K words
2025-01-140001213900-25-003492EDGAR1K words

89 total filings indexed. 71 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

post-traumatic-stress-disorder-(ptsd) social-anxiety-disorder-(sad) alzheimer's-disease-/-cognitive-dysfunction oncology-(metastatic-colorectal-cancer,-metastatic-breast-cancer)

Company Identity

CIK0001191070
TickerNEUP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedC3
Websitehttps://www.neuphoriatx.com
Listed2021-12-16

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: e148d7f341fed00ac9fb0fa09f70328af586f5563a34122992991fe7cb9cc686
parent: 7259d3ed83ad5a55ae2e207e094771f291a51c198366b16952accf43be6b6db3
content hash: 0af8d26434ffa54800434b7034e9ad417552efaf9b7286bdd8fc1209d4eb9322
signed: 2026-09-28T19:02:19.571Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up NEUP using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on NEUP, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/NEUP (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.